Cassiopea Announces Results for First Quarter 2020
Cassiopea S.p.A., a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today its interim first quarter results for the period ended 31 March 2020.